研究実績

A Multicenter Phase 2 Trial of Ramucirumab Plus Irinotecan in Patients with Early Relapsed Gastric Cancer During or After Adjuvant Docetaxel Plus S-1 Therapy: RAMIEL Trial (OGSG1901)

Hidekazu Hirano, Toshifumi Yamaguchi, Ryohei Kawabata, Yusuke Akamaru, Keijiro Sugimura,

Masaaki Motoori, Yoshihiro Kakeji,  Yosuke Kito, Takashi Nomura, Takeshi Kawakami,

Masahiro Tanemura, Atsushi Takeno, Hiroyuki Okuda, Tomohiro Matsushima, Toshio Shimokawa, Yukinori Kurokawa, Shunji Endo, Narikazu Boku, Taroh Satoh

第98回日本胃癌学会総会(JGCA2026)2026.3.4-6 沖縄

前の記事 次の記事 一覧ページへ戻る